Nevro

NVRO NYSE
64.25
+0.75
+1.18%
交易中 13:31 06/19 EDT
开盘
63.40
昨收
63.50
最高
64.99
最低
63.01
成交量
14.28万
成交均量(3M)
60.74万
52周最高
86.75
52周最低
34.75
换手率
0.47%
市值
19.61亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Nevro NVRO股票价格,Nevro股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Nevro Corp. is a global medical device company. The Company focuses on providing products that improve the quality of life of patients suffering from chronic pain. The Company has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain. HF10 therapy enables patients to achieve sustained pain relief without paresthesia, thus enabling its patients to avoid the uncomfortable shocking or jolting sensations commonly associated with paresthesia. HF10 therapy relies on consistent anatomical lead placement. As of December 31, 2016, it was investigating the use of HF10 therapy to address additional indications, such as chronic upper limb and neck pain, painful neuropathies and non-surgical refractory back pain. The Senza system is approved to create electrical impulses from 2 hertz (Hz) to 10,000 Hz.
展开 >

最近浏览

名称
价格
涨跌幅